Johnson & Johnson seeds an ambitious open R&D program
Just how far can you go with an open R&D approach to drug development? Johnson & Johnson is stepping up with $3 million to seed a new program that intends to find out. J&J has set up a group called Healthy Minds, which will assist the International Mental Health Research Organization in setting up a collaborative effort on neuroscience